Search Results

Gain the latest insights into the biopharma hiring landscape with BioSpace’s Biopharma Job Market Report Q2 2026. Explore the trends shaping talent acquisition, from rising job postings and sustained R&D hiring to the market activity signaling stronger hiring demand ahead.

The patented approach makes NMR technology more reliable and easier to use across different laboratories.

Drug discovery teams have more data than ever, but turning that data into actionable insight remains a major challenge. In this candid conversation, Patsnap’s Ben Coverdale is joined by Mark Davies, Head of Product for Life Sciences, and James Longden, Senior Director, Life Sciences at Evolvus to explore how AI-powered intelligence is reshaping candidate optimization across antibodies, ADCs, and peptides.

• New research based on directly measured metrics of patients in a randomized, placebo-controlled clinical trial provides a mechanistic explanation for the clinical benefit provided by the antimicrobial agent clarithromycin in patients with community-acquired pneumonia (CAP). • Insights argue for effects of clarithromycin on immune function and inflammation in addition to its acknowledged antimicrobial action

While agents like AbbVie’s Humira have transformed the treatment landscape, not all patients benefit equally from the drug. Better biomarker analysis and more investment in mechanistic trials can inform the development of more effective therapies with broader clinical value.